IL-27 attenuates IL-23 mediated inflammatory arthritis

Area of Science:

• Immunology
• Autoimmunity
• Inflammation Research

Background:

• Interleukin 27 (IL-27) exhibits dual roles in autoimmunity, with known anti-inflammatory effects on Th17 cells.
• The impact of IL-27 on myeloid cells in inflammatory conditions remains less understood.

Purpose of the Study:

• To investigate the role of IL-27 in regulating IL-23-induced inflammation, focusing on myeloid cell populations.
• To elucidate the immunosuppressive mechanisms of IL-27 in the context of inflammatory arthritis.

Main Methods:

• Analysis of myeloid cell infiltration in joints and spleens.
• Quantification of myeloid cell populations in spleen and bone marrow.
• Assessment of IL-27's effect on IL-23-driven inflammatory responses.

Main Results:

• IL-27 significantly inhibited IL-23-induced inflammation, reducing myeloid cell infiltration in joints.
• IL-27 decreased specific myeloid cell subsets (CD11b+ GR1+ and CD3-CD11b+CD11c-GR1-) in the spleen.
• Reduced myeloid cell levels were observed in the spleen and bone marrow following IL-27 treatment.

Conclusions:

• IL-27 demonstrates a significant immunosuppressive function by modulating IL-23-dependent myelopoiesis.
• IL-27 plays a critical role in controlling joint inflammation by negatively regulating myeloid cell expansion.
• These findings highlight IL-27 as a potential therapeutic target for inflammatory arthritis.